View full meeting coverage »

Eyetube Meeting Coverage:

American Academy of Ophthalmology Annual Meeting 2020

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Evaluation of Avacincaptad Pegol for the Treatment of GA Associated With AMD

Donald J. D'Amico, MD, presents the 18-month data of the phase 2/3 GATHER1 trial, which evaluated the monthly intravitreal injection of the novel C5 inhibitor avacincaptad pegol (Zimura, Iveric bio) for the treatment of geographic atrophy associated with AMD.

Age-Related Macular Degeneration (AMD) • Clinical Trials • geographic atrophy, GA • Intravitreal Injection • IVERIC bio • retina-meeting-recap


5 / 25 Series: American Academy of Ophthalmology Annual Meeting 2020


More Videos in this Series


View full meeting coverage (25 videos)
These programs are not affiliated with the official program of AAO 2020.